Low rates of antibiotic use among ambulatory patients with coronavirus disease 2019 (COVID-19).
Journal
Antimicrobial stewardship & healthcare epidemiology : ASHE
ISSN: 2732-494X
Titre abrégé: Antimicrob Steward Healthc Epidemiol
Pays: England
ID NLM: 9918266096106676
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
23
5
2022
pubmed:
24
5
2022
medline:
24
5
2022
Statut:
ppublish
Résumé
We assessed the prevalence of antibiotic prescriptions among ambulatory patients tested for coronavirus disease 2019 (COVID-19) in a large public US healthcare system and found a low overall rate of antibiotic prescriptions (6.7%). Only 3.8% of positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) tests were associated with an antibiotic prescription within 7 days.
Identifiants
pubmed: 35601658
doi: 10.1017/ash.2022.17
pmc: PMC9119305
mid: NIHMS1797797
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NCATS NIH HHS
ID : TL1 TR002382
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002378
Pays : United States
Déclaration de conflit d'intérêts
Conflicts of interest. The authors report no conflicts of interest relevant to this article.
Références
Clin Infect Dis. 2021 Aug 2;73(3):e652-e660
pubmed: 33373435
Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
Infect Control Hosp Epidemiol. 2021 Jan;42(1):89-92
pubmed: 32703323
Lancet Microbe. 2021 Aug;2(8):e354-e365
pubmed: 34100002
Clin Microbiol Infect. 2021 Feb 16;:
pubmed: 33601010
Clin Microbiol Infect. 2021 Aug;27(8):1158-1166
pubmed: 33915287
J Clin Virol. 2018 May;102:42-49
pubmed: 29494950
J Clin Microbiol. 2016 Dec;54(12):2950-2955
pubmed: 27654334